Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 910292 | ISIN: FR0000038242 | Ticker-Symbol: QTL
Frankfurt
06.06.25 | 08:04
13,950 Euro
-0,36 % -0,050
1-Jahres-Chart
LUMIBIRD SA Chart 1 Jahr
5-Tage-Chart
LUMIBIRD SA 5-Tage-Chart
RealtimeGeldBriefZeit
13,85014,25006.06.

Aktuelle News zur LUMIBIRD Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
20.05.Lumibird und Rheinmetall schließen strategische Partnerschaft für militärische Lasersysteme57
12.05.Lumibird Receives Laser Rangefinder Orders For Skyranger 30154Lannion, 12 May 2025 - 5.45pm LUMIBIRD RECEIVES LASER RANGEFINDER ORDERS FOR SKYRANGER 30 The Lumibird Group (FR0000038242 - LBIRD), European leader in laser technologies, announces that its subsidiary...
► Artikel lesen
28.04.Lumibird: Revenue Growth Of+ 12.4% In The 1st Quarter101Lannion, 28 April 2025 - 5.45pm REVENUE GROWTH OF+ 12.4% IN THE 1st QUARTER The Lumibird Group (FR0000038242 - LBIRD), European leader in laser technologies, recorded consolidated revenue growth of+...
► Artikel lesen
21.03.Lumibird: ACCESS TO PREPARATORY DOCUMENTS FOR THE COMBINED GENERAL MEETING ON APRIL 29, 20253
LUMIBIRD Aktie jetzt für 0€ handeln
11.03.Lumibird: Annual Results 2024401Lannion, 11/03/2025 - 5:45pm ANNUAL RESULTS 2024 EBITDA margin(1) of 15.9%, of which 20.6% for the Medical division and 10.8% for the Photonics divisionStrong growth in the 2nd half with 20.2% EBITDA...
► Artikel lesen
27.01.Lumibird: 2024 Sales At €207.1m (+1.7% -reported)186Lannion, 27/01/2025 - 5.45pm LUMIBIRD: 2024 SALES AT €207.1M (+1.7% -REPORTED) Medical Division: €107.7m (+4.8% on a reported basis), a recovery confirmed by a new record for billings in Q4 of €33.5m...
► Artikel lesen
24.01.Lumibird: FINANCIAL COMMUNICATIONS AGENDA1
27.11.24Lumibird: Exploratory Project To Sell The Medical Division158Lannion, November 27, 2024 - 8:00 am LUMIBIRD: EXPLORATORY PROJECT TO SELL THE MEDICAL DIVISION Following market rumours, Lumibird (FR0000038242 - LBIRD) confirms that it is currently exploring the...
► Artikel lesen
21.10.24Lumibird: Q3 Revenue - Agreement Signed To Acquire The Continuum Product Range From The Amplitude Laser Group662Lannion, October 21, 2024 - 5:55 pm Q3 REVENUEAGREEMENT SIGNED TO ACQUIRE THE CONTINUUM PRODUCT RANGE FROM THE AMPLITUDE LASER GROUP Growth upturn in Q3 for the Medical Division, stability for the...
► Artikel lesen
15.10.24Lumibird: Banks Renew Their Confidence In The Group's Strategy With Financing Of Over €100m208Lannion, October 15, 2024 - 17:45 pm LUMIBIRD: BANKS RENEW THEIR CONFIDENCE IN THE GROUP'S STRATEGY WITH FINANCING OF OVER €100M 55.2m repayable over 7 years, to reschedule existing loans50m to be...
► Artikel lesen
24.07.24Lumibird Receives New Orders From Thales496Lannion, July 24, 2024 - 17:35 LUMIBIRD RECEIVES NEW ORDERS FROM THALES The LUMIBIRD Group (FR0000038242 - LBIRD), a European leader in laser technologies, announces that Lumibird Photonics Sweden...
► Artikel lesen
22.07.24Lumibird: H1 2024 revenues340Lannion, July 22, 2024- 5:45 pm H1 2024 REVENUES Slight increase to €98m (+1%) with a base effect (H1 2023 growth of +16% vs H1 2022) 3-year target maintained for revenue growth (CAGR +8%) and profitability...
► Artikel lesen
12 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1